XNSE
TAKE
Market cap39mUSD
Nov 12, Last price
26.16INR
Name
Take Solutions Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
TAKE Solutions Limited is a global provider of specialized services across the life sciences and supply chain management sectors. Within the life sciences domain, the company utilizes its technological expertise to deliver offerings such as clinical trial support, generics development, data analytics, regulatory compliance, and pharmacovigilance, along with patient safety services. It also designs digital and mobile platforms to foster patient-centric insights and offers cloud-based payer solutions for billing data access. Moreover, it provides integrated digital solutions for payers and providers, focusing on personalized healthcare, wellness initiatives, and enhanced patient engagement. Its medical device services encompass technological advancements, including chip-level programming, wearables, DICOM devices, PROM, nano devices, and various sensors. Established in 2000, the company's headquarters are located in Chennai, India, and it operates as a subsidiary of TAKE Solutions Pte. Limited.
Related entities
Parent
TAKE SOLUTIONS PTE. LTD.
Key people
Non-Executive Independent Chairman of the Board · since 2009
Vice Chairman of the Board, Managing Director · since 2013
Avaneesh Singh
Compliance Officer, Company Secretary · since 2016
N S. Shobana
Additional Executive Director · since 2017
Subhasri Sriram
Chief Financial Officer, Additional Executive Director · since 2017
S. Srinivasan
Additional Non-Executive Director · since 2013
Raman Kapur
Independent Director · since 2015
Uma Ratnam Krishnan
Independent Director · since 2014
Rangaswamy Sundara Rajan
Independent Director · since 2005
Balasubramanian Srinivasan
Additional Independent Director · since 2019
Headquarters & legal address
NO 56 OLD NO 116 4TH FLOOR RAGAS BUILDING DR. RADHAKRISHNAN SALAI MYLAPORE,
CHENNAI, TN 600004
IN
CHENNAI, TN 600004
IN
Valuation
Title INR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑03 | 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||